AnaptysBio SG&A Expense (Quarterly) Insights

AnaptysBio Inc (ANAB)

23.94 +0.29 (+1.23%) USD | NASDAQ | May 31, 16:00

23.86 -0.08 (-0.33%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	12.34M
December 31, 2023	10.28M
September 30, 2023	10.17M
June 30, 2023	10.68M
March 31, 2023	10.82M
December 31, 2022	9.407M
September 30, 2022	8.862M
June 30, 2022	8.171M
March 31, 2022	10.20M
December 31, 2021	5.392M
September 30, 2021	5.432M
June 30, 2021	5.246M
March 31, 2021	5.423M
December 31, 2020	5.088M
September 30, 2020	4.794M
June 30, 2020	4.687M
March 31, 2020	4.285M
December 31, 2019	3.832M
September 30, 2019	3.814M
June 30, 2019	4.307M

Date	Value
March 31, 2019	4.141M
December 31, 2018	3.743M
September 30, 2018	4.004M
June 30, 2018	3.832M
March 31, 2018	3.947M
December 31, 2017	2.545M
September 30, 2017	2.39M
June 30, 2017	2.35M
March 31, 2017	2.053M
December 31, 2016	0.912M
September 30, 2016	1.007M
June 30, 2016	1.152M
March 31, 2016	1.219M
December 31, 2015	1.074M
September 30, 2015	0.889M
June 30, 2015	0.944M
March 31, 2015	0.682M
December 31, 2014	0.574M
September 30, 2014	0.55M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

3.814M

Minimum

Sep 2019

12.34M

Maximum

Mar 2024

7.161M

Average

5.428M

Median

SG&A Expense (Quarterly) Benchmarks